CAR T cell therapy makes strides in tackling Hodgkin lymphoma
CAR-T cell therapy has been used to treat Hodgkin lymphoma with remarkable success for the first time in an early phase clinical trial.
Read moreCAR-T cell therapy has been used to treat Hodgkin lymphoma with remarkable success for the first time in an early phase clinical trial.
Read moreFrom the Labs celebrates Baylor Women in Science! Here is the second one in the series. (See the other Women in Science posts here)
Read moreSince he was in college, Thomas Shum wanted to pursue a career in cancer research. As he advanced in his studies, he was able to
Read moreT cell therapies have demonstrated encouraging results and benefits in patients with lymphoma resistant to chemotherapy, but, despite these advances, a large number of patients
Read moreA bone marrow transplant can be a life-saving treatment for patients with certain cancers and other serious illnesses that have not responded to conventional chemotherapies.
Read moreTreating cancer with the patient’s own immune cells has been successful. In particular, treating B cell malignancies with the patients’ own immune T cells modified
Read moreWe hope you have recuperated after last week’s brief holiday break. Catch up on news from Baylor College of Medicine and other headlines related to
Read more